Work

Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with tenofovir/emtricitabine – multicenter comparative trial vs efavirenz in naїve HIV patients

Year: 2017

Type: article

Source: Infekcionnye bolezni

DOI: 10.20953/1729-9225-2017-3-5-13

Authors: A.V. Kravchenko, E.A. Orlova-Morozova, T.E. Shimonova, O.A. Kozyrev, F.I. Nagimova, N.G. Zakharova, E.S. Ivanova, U.A. Kuimova, O.S. Efremova, D.B. Sonin, O.E. Chernova, O.S. Tonkikh, A.A. Yakovlev, N.V. Kurina, V.V. Pokrovsky, V.V. Bichko, N.V. Vostokova, O.V. Zozulya

Institutions: Central Research Institute of Epidemiology, Centre for Prevention and Control of AIDS and Infectious Diseases, Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Regional Center for the Prevention and Control of AIDS Volgograd, The First Republican Clinical Hospital of the Ministry of Health of the Udmurt Republic, Viriom Inc. (United States)

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2765190826

FWCI: 0.21

Cites:

Cited by: 2

Related to: 10